abstract |
The present invention includes compounds of formula (I): Formula (I)] Wherein X, R 1 , R 2 , R 3 , and R 4 are as defined in the specification and claims. The invention also includes methods for preventing, treating or ameliorating syndromes, disorders or diseases that are type II diabetes, obesity or asthma. The invention also relates to a method of inhibiting CCR2 activity in a mammal by administering a therapeutically effective amount of at least one compound of formula (I). |